4D Molecular Therapeutics (FDMT) slipped ~15% on Wednesday after the company announced updated data from an early-stage trial for 4D-710, its experimental therapy for a genetic disorder known as ...
EMERYVILLE, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
The architecture, engineering, and construction (AEC) sector has always depended on visualization technology. From hand-drawn sketches to blueprints, to CAD models and photorealistic renderings, each ...
Faster, more intuitive web interface with integrated search, improved visual organization and unified configuration/diagnostic tools eliminate time-consuming ...
4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...
Will AI help you work or replace you? Check yourself. July 28, 2025 Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. That ...
Cryo-EM structures of human aquaporin AQP2 bound to the anti-trypanosomal drugs pentamidine and melarsoprol identify the molecular mechanism for drug-resistant sleeping sickness.
What makes a data visualization truly memorable? Is it the sleek design, the clever use of color, or the ability to distill complex information into something instantly understandable? The truth is, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback